1 / 39

Prescription Drug Misuse: Findings from SAMHSA’s National Surveys

Prescription Drug Misuse: Findings from SAMHSA’s National Surveys. Charlene Lewis, Ph.D. Senior Advisor Office of Applied Studies, SAMHSA This presentation was modified from its original format for 508 compliancy. 2006 National Survey on Drug Use and Health (NSDUH). NSDUH Design.

JasminFlorian
Download Presentation

Prescription Drug Misuse: Findings from SAMHSA’s National Surveys

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Prescription Drug Misuse: Findings from SAMHSA’s National Surveys Charlene Lewis, Ph.D. Senior Advisor Office of Applied Studies, SAMHSA This presentation was modified from its original format for 508 compliancy.

  2. 2006 National Survey on Drug Use and Health (NSDUH)

  3. NSDUH Design • Representative nationally and in each state • Civilian, noninstitutional population, age 12+ • Face-to-face interview • Computer-assisted, self-administered • 67,802 respondents in 2006

  4. Prevalence of Illicit Drug Use

  5. Past Month Use of Specific Illicit Drugs among Persons Aged 12 or Older: 2006

  6. Past Month Percentage Use of Selected Illicit Drugs among Persons Aged 12 or Older: 2002-2006 +Difference between this estimate and the 2006 estimate is statistically significant at the 0.05 level.

  7. Past Month Nonmedical Percentage Use of Prescription Drugs (Psychotherapeutics) among Persons Aged 12 and Older: 2002-2006 +Difference between this estimate and the 2006 estimate is statistically significant at the 0.05 level.

  8. Source of Pain Relievers for Most Recent Nonmedical Use among Past Year Users Aged 12 or Older: 2006 Source where respondent obtained Source where friend/relative obtained • Note: Totals may not sum to 100% because of rounding or because suppressed estimates are not shown. • 1The Other category includes the sources: “Wrote Fake Prescription,” “Stole from Doctor’s Office/Clinic/Hospital/Pharmacy,” and “Some Other Way.”

  9. Past Month Illicit Percentage Drug Use among Persons Aged 12+, by Age: 2002-2006 +Difference between this estimate and the 2006 estimate is statistically significant at the 0.05 level.

  10. Past Month Nonmedical Use of Prescription Drugs among Young Adults Aged 18 to 25: 2002-2006 +Difference between this estimate and the 2006 estimate is statistically significant at the 0.05 level.

  11. Initiation of Drug Use

  12. Past Year Initiates for Specific Illicit Drugs among Persons Aged 12 or Older: 2006

  13. Mean Age at First Use for Specific Illicit Drugs among Past Year Initiates Aged 12 to 49: 2006

  14. Abuse and Dependence

  15. Substance Dependence or Abuse in the Past Year among Persons Aged 12+: 2002-2006

  16. Dependence on or Abuse of Specific Illicit Drugs in the Past Year among Persons Aged 12 or Older: 2006

  17. Treatment Episode Data Set (TEDS) Admissions to Substance Abuse Treatment for the Abuse of Opioid Analgesics

  18. Treatment Episode Data Set (TEDS) Client-level information on treatment admissions Primarily from facilities receiving public funds Estimated coverage – 80% 1.8 million admissions annually

  19. TEDS Data Elements Demographic variables Drug use history Top 3 substances of abuse at admission Route of administration Frequency of use Age at first use Treatment variables

  20. Limitations of TEDS Drugs of abuse reported in “generic” categories, not specific brand names or formulations All States report on “opiates other than heroin” as a group Only 16 States report on specific opioid analgesics

  21. Treatment Admissions by Primary Substance: 2006 * Includes admissions where primary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone.

  22. Treatment Admissions Involving Opioid Analgesics*: 1992-2006 * Includes admissions where primary, secondary, or tertiary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone.

  23. Percent Increase in Admissions for Heroin and Opioid Analgesics*:1997-2006 *Includes admissions where primary, secondary, or tertiary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone.

  24. Alabama Hawaii Idaho Kentucky Maine Maryland Mississippi Missouri Includes admissions where primary, secondary, or tertiary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone. New Hampshire New Jersey New Mexico Nevada New York North Dakota Ohio South Dakota States Reporting Specific Opioid Analgesics*: 2006

  25. Admissions Involving Specific Opioid Analgesics*: 2006 *Data submitted by 16 States: AL, HI, ID, KY, MD, ME, MO, MS, ND, NH, NJ, NM, NV, NY, OH, SD

  26. Percent Increase in Admissions for Specific Opioid Analgesics*:2000-2006 *Includes admissions where primary, secondary, or tertiary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone. Analysis restricted to 13 States that reported detailed drug codes for 2000 and 2006.

  27. Opioid Analgesic1 Admission Rates Per 100,000 Population Aged 12 and Over By State*: 2006 *Includes admissions where primary, secondary, or tertiary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone.

  28. Opioid AnalgesicTreatment Admission Rates per 100,000 age 12 and over by Urbanization*: 2000 and 2006 • MSA = Metropolitan Statistical Area • *Includes admissions where primary, secondary, or tertiary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone.

  29. Percent of Primary and Secondary Opioid Analgesic Admissions Using Other Substances: 2006

  30. Treatment Admissions Involving Opioid Analgesics by Age and Route of Administration*: 2006 *Includes admissions where primary, secondary, or tertiary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone.

  31. Characteristics of Opioid Analgesic Admissions*: 1997 and 2006 *Includes admissions where primary, secondary, or tertiary substance was reported as Other opiates/synthetics. Excludes admissions for non-prescription use of methadone.

  32. Drug Abuse Warning Network(DAWN)

  33. The DAWN – ED Sample • National probability sample of non-Federal, short-stay, general hospitals that operate 24-hour emergency departments • Annual estimates of drug-related emergency department visits

  34. How DAWN Works: Retrospective Review of Medical Records • Charts reviewed: 11,814,043 • Cases found: 374,541 • Source of National estimates • Source: DAWN, 2005 data, 4/6/2006

  35. Definition of a “Case” Nonmedical use of pharmaceuticals • Exceeded prescribed or recommended dose • Used drugs prescribed for another • Poisoned with malicious purpose • Substance abuse

  36. Nonmedical Use of Pharmaceuticals, ED Visit Rates by Age and Gender: 2006

  37. Drug Misuse and Abuse in ED Visits • Source: DAWN estimates for the U.S., 2006

  38. Nonmedical Use: Disposition from ED, Selected Opiates/Opioids, 2004 Hydrocodone products All opiates/opioids Oxycodone products

  39. For further information: • On the web: http://www.oas.samhsa.gov • By Phone: 240-276-1212 • For Publications: 1-877-SAMHSA7

More Related